The DOI matches its Crossref record; 249 of the 249 references it cites were found in a registry or an index.
Causes and consequences of DNA hypomethylation in human cancer
Abstract
While specific genes are hypermethylated in the genome of cancer cells, overall methylcytosine content is often decreased as a consequence of hypomethylation affecting many repetitive sequences. Hypomethylation is also observed at a number of single-copy genes. While global hypomethylation is highly prevalent across all cancer types, it often displays considerable specificity with regard to tumor type, tumor stage, and sequences affected. Following an overview of hypomethylation alterations in various cancers, this review focuses on 3 hypotheses. First, hypomethylation at a single-copy gene may occur as a 2-step process, in which selection for gene function follows upon random hypo methylation. In this fashion, hypomethylation facilitates the adaptation of cancer cells to the ever-changing tumor tissue microenvironment, particularly during metastasis. Second, the development of global hypomethylation is intimately linked to chromatin restructuring and nuclear disorganization in cancer cells, reflected in a large number of changes in histone-modifying enzymes and other chromatin regulators. Third, DNA hypomethylation may occur at least partly as a consequence of cell cycle deregulation disturbing the coordination between DNA replication and activity of DNA methyltransferases. Finally, because of their relation to tumor progression and metastasis, DNA hypomethylation markers may be particularly useful to classify cancer and predict their clinical course.Key words : chromatin regulator proteins, retrotransposon, metastasis, chromosomal instability, methyltransferase, ectopic expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–249 of 249
DNMT1 is a Component of a Multiprotein DNA Replication Complex
Vertino, P. M., Sekowski, J. W., Coll, J. M., Applegren, N., Han, S., Hickey, R. J., & Malkas, L. H. (2002) · Cell Cycle · doi:10.4161/cc.1.6.270 · Cited by 82
Yin, H., & Blanchard, K. L. (2000) · Blood · doi:10.1182/blood.v95.1.111 · Cited by 81
Stromal Cell Involvement in Cancer
Almholt, K., & Johnsen, M. (2003) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-59349-9_3 · Cited by 79
Porter, J. F., Shen, S., & Denhardt, D. T. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601533 · Cited by 77
The Rb/chromatin connection and epigenetic control: opinion
Ferreira, R., Naguibneva, I., Pritchard, L. L., Ait-Si-Ali, S., & Harel-Bellan, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204337 · Cited by 76
Robertson, A. K., Geiman, T. M., Sankpal, U. T., Hager, G. L., & Robertson, K. D. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.083 · Cited by 75
Gotzinger, N., Sauter, M., Roemer, K., & Mueller-Lantzsch, N. (1996) · Journal of General Virology · doi:10.1099/0022-1317-77-12-2983 · Cited by 74
Control of Genes by Mammalian Retroposons
Tomilin, N. (1998) · International review of cytology · doi:10.1016/s0074-7696(08)61050-5 · Cited by 73
Role of the ras-MAPK Signaling Pathway in the DNA Methyltransferase Response to DNA Hypomethylation
Deng, C., Yang, J., Scott, J. M., Hanash, S., & Richardson, B. C. (1998) · Biological Chemistry · doi:10.1515/bchm.1998.379.8-9.1113 · Cited by 73
HERV‐K(HML‐2) GAG/ENV antibodies as indicator for therapy effect in patients with germ cell tumors
Kleiman, A., Senyuta, N., Tryakin, A., Sauter, M., Karseladze, A., Tjulandin, S., Gurtsevitch, V., & Mueller-Lantzsch, N. (2004) · International Journal of Cancer · doi:10.1002/ijc.11649 · Cited by 70
DNA Methylation and Cancer Therapy
Szyf, M. (2005) · Springer eBooks · doi:10.1007/b139080 · Cited by 69
Relationship Between Transcription and DNA Methylation
Chan, M. F., Liang, G., & Jones, P. A. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59696-4_5 · Cited by 68
Cho, M., Uemura, H., Kim, S., Kawada, Y., Yoshida, K., Hirao, Y., Konishi, N., Saga, S., & Yoshikawa, K. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1951 · Cited by 67
Li, S., Chiang, T.-C., Richard-Davis, G., Barrett, J. C., & McLachlan, J. A. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00194-x · Cited by 65
DNA methylation and cancer therapy
Szyf, M. (2003) · Drug Resistance Updates · doi:10.1016/j.drup.2003.10.002 · Cited by 65
Tamimi, Y., van der Poel, H. G., Karthaus, H. F. M., Debruyne, F. M. J., & Schalken, J. A. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.403 · Cited by 64
Effects of methylation on expression of TMS1/ASC in human breast cancer cells
Levine, J. J., Crider, K. S., & Vertino, P. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206430 · Cited by 64
Liu, W. M., Guerra-Vladusic, F. K., Kurakata, S., Lupu, R., & Kohwi-shigematsu, T. (1999) · PubMed · Cited by 63
Erythropoietin and erythropoietin receptor expression in human prostate cancer
Arcasoy, M. O., Amin, K., Vollmer, R. T., Jiang, X., Demark‐Wahnefried, W., & Haroon, Z. A. (2004) · Modern Pathology · doi:10.1038/modpathol.3800288 · Cited by 63
Rössler, J. K., Stolze, I. P., Frede, S., Freitag, P., Schweigerer, L., Havers, W., & Fandrey, J. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20133 · Cited by 63
Insulator and silencer sequences in the imprinted region of human chromosome 11p15.5
Du, M., Beatty, L. G., Zhou, W., Lew, J. M., Schoenherr, C. J., Weksberg, R., & Sadowski, P. D. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg194 · Cited by 63
Another Tie that Binds the MTA Family to Breast Cancer
Kumar, R. (2003) · Cell · doi:10.1016/s0092-8674(03)00274-5 · Cited by 61
Takaha, N., Hawkins, A. L., Griffin, C. A., Isaacs, W. B., & Coffey, D. S. (2002) · PubMed · Cited by 57
Florl, A. R., Franke, K. H., Niederacher, D., Gerharz, C., Seifert, H., & Schulz, W. A. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780161 · Cited by 57
Self-citationDna methylation in the immune system
Teitell, M. A., & Richardson, B. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00224-9 · Cited by 56
Ogasawara, S., Maesawa, C., Yamamoto, M., Akiyama, Y., Wada, K., Fujisawa, K., Higuchi, T., Tomisawa, Y., Sato, N., Endo, S., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207211 · Cited by 56
The role of DNA methyltransferase 1 in growth control
Szyf, M. (2001) · Frontiers in bioscience · doi:10.2741/szyf · Cited by 55
Loss of methylation at chromosome 11p15.5 is common in human adult tumors
Scelfo, R. A., Schwienbacher, C., Veronese, A., Gramantieri, L., Bolondi, L., Querzoli, P., Nenci, I., Calin, G. A., Angioni, A., Barbanti‐Brodano, G., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205336 · Cited by 54
Takaha, N., Resar, L. M. S., Vindivich, D., & Coffey, D. S. (2004) · The Prostate · doi:10.1002/pros.20049 · Cited by 53
Dante, R., Dante-Paire, J., Rigal, D., & Roizès, G. (1992) · PubMed · Cited by 53
Human DNA methyltransferase gene DNMT1 is regulated by the APC pathway
Campbell, P. M. (2003) · Carcinogenesis · doi:10.1093/carcin/24.1.17 · Cited by 49
Fang, J. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i23.3394 · Cited by 49
Retinoblastoma tumor suppressor and genome stability
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)85002-3 · Cited by 48
Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines
Raschke, S., Balz, V., Efferth, T., Schulz, W. A., & Florl, A. R. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20119 · Cited by 47
Self-citationTranscriptional regulation of the human LINE-1 retrotransposon L1.2B
Steinhoff, C., & Schulz, W. A. (2003) · Molecular Genetics and Genomics · doi:10.1007/s00438-003-0931-2 · Cited by 46
Self-citationHigh-mobility-group proteins and cancer - an emerging link
Wunderlich, V., & B�ttger, M. (1997) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01214665 · Cited by 45
Demethylation of DNA by decitabine in cancer chemotherapy
Brown, R. E., & Plumb, J. A. (2004) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.4.4.501 · Cited by 43
CTCF Gene Mutations in Invasive Ductal Breast Cancer
Aulmann, S., Bläker, H., Penzel, R., Rieker, R. J., Otto, H. F., & Sinn, H. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1024930404629 · Cited by 41
Peculiar structure and location of 9p21 homozygous deletion breakpoints in human cancer cells
Florl, A. R., & Schulz, W. A. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10192 · Cited by 39
Self-citationEpigenetic variability and the evolution of human cancer
OHLSSON, R. I., Kanduri, C., Whitehead, J., Pfeifer, S., Lobanenkov, V. V., & Feinberg, A. P. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)88306-9 · Cited by 38
Subcellular distribution of HP1 proteins is altered in ICF syndrome
Luciani, J., Depetris, D., Missirian, C., Mignon‐Ravix, C., Metzler‐Guillemain, C., Mégarbané, A., Moncla, A., & Mattéi, M. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201293 · Cited by 38
The rise and fall of genomic methylation in cancer
El‐Osta, A. (2003) · Leukemia · doi:10.1038/sj.leu.2403218 · Cited by 38
Hypomethylation of the XIST Gene Promoter in Prostate Cancer
Laner, T., Schulz, W. A., Engers, R., Müller, M., & Florl, A. R. (2005) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504005776404607 · Cited by 37
Self-citationX chromosome inactivation: theme and variations
Migeon, B. R. (2002) · Cytogenetic and Genome Research · doi:10.1159/000071568 · Cited by 35
Mesquita, P. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00549-9 · Cited by 34
Proliferation Stage-dependent Expression of DNA Methyltransferase (Dnmt1) in Mouse Small Intestine.
Suetake, I., Shi, L., Watanabe, D., Nakamura, M., & Tajima, S. (2001) · Cell Structure and Function · doi:10.1247/csf.26.79 · Cited by 23
Intracellular distribution of DNA methyltransferase during the cell cycle
Vogel, M. C., Papadopoulos, T. G., Müller-Hermelink, H. K., et al. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80275-8 · Cited by 18
Schwarz, S., Bourgeois, C. A., Soussaline, F. P., Homsy, C., Podestà, A., & Jost, J. (2000) · European Journal of Cell Biology · doi:10.1078/0171-9335-00070 · Cited by 12
Suppression of clonogenicity by mammalian Dnmt1 mediated by the PCNA-binding domain
Santourlidis, S., Kimura, F., Fischer, J., & Schulz, W. A. (2004) · Biochemistry and Cell Biology · doi:10.1139/o04-099 · Cited by 2
Self-citation
Cited by
Epigenetic therapy of cancer: past, present and future
Yoo, C. B., & Jones, P. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1930 · Cited by 1,289
Dna Hypomethylation In Cancer Cells
Ehrlich, M. (2009) · Epigenomics · doi:10.2217/epi.09.33 · Cited by 1,060
DNA hypomethylation and human diseases
Wilson, A. S., Power, B. E., & Molloy, P. L. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.007 · Cited by 804
Reactive Oxygen Species (ROS)––Induced genetic and epigenetic alterations in human carcinogenesis
Ziech, D., Franco, R., Pappa, A., & Panayiotidis, M. I. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.02.015 · Cited by 568
Cancer/testis (CT) antigens: Potential targets for immunotherapy
Caballero, O. L., & Chen, Y. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01303.x · Cited by 554
Metadata
- Authors
- Hoffmann, M. J., & Schulz, W. A.
- Venue
- Biochemistry and Cell Biology
- Publisher
- Canadian Science Publishing
- Published
- 2005-06-01
- Volume
- 83
- Issue
- 3
- Pages
- 296-321
- ISSN
- 0829-8211 (ISSN-L)
- 1208-6002
- OpenAlex
- W2128472685
- Cited by
- 252
- References
- 249
- FWCI
- 5.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.